Gene polymorphisms of the Vascular Endothelial Growth Factor (VEGF) in Promotor Region -2578 C/A and -460 T/C as a Risk Factor of Diabetic Retinopathy in Egyptian Patients with D - Egyptian Knowledge Bank

392313

Gene polymorphisms of the Vascular Endothelial Growth Factor (VEGF) in Promotor Region -2578 C/A and -460 T/C as a Risk Factor of Diabetic Retinopathy in Egyptian Patients with D

Article

Last updated: 05 Jan 2025

Overview Similar Items

Article

VEGF Gene Polymorphisms as a Genetic Biomarkers for Diabetic Retinopathy

Thesis

Association of vascular endothelial growth factor gene polymorphism with diabetic retinopathy in type 2 diabetes mellitus in Egyptian patients

Article

Genetic Polymorphisms of Vascular Endothelial Growth Factor (VEGF) in Egyptian Women with Breast Cancer

Thesis

Association of VEGF gene polymorphisms with type 2 diabetic retinopathy

Article

Association of Complement Factor H (CFH) Y402H Gene Polymorphism and Serum CFH with Risk of Age Related Macular Degeneration in Egyptian Patients

Article

The Influence of C936T Gene Polymorphism of the vascular endothelial growth factor and biochemical variants for Alpha-Fetoprotein in hepatocellular carcinoma Patients in Egypt

Thesis

Vascular endothelial growth factor 634G/C gene polymorphism in prognosis of hepatocellular carcinoma in Egyptian patients

Article

Gene polymorphisms and risk of preeclampsia in Egyptian women

Article

Genetic variants of vascular endothelial growth factor gene polymorphism affect the risk and severity of ischemic stroke: a case–control study

Article

Angiotensin Converting Enzyme Insertion/Deletion Gene Polymorphism in Egyptian Population with Type 2 Diabetes and Its Relation to Diabetic Nephropathy